Loading…
LeMaitre Vascular, Inc. is projected to rise to $116.38 by 2027, a +13% move from its current price of $102.74. LMAT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $100.81 | $102.74 | $104.70 | 0.00% |
| Jul 14 | $100.03 | $102.74 | $105.53 | 0.00% |
| Jul 15 | $99.43 | $102.74 | $106.16 | 0.00% |
| Jul 16 | $98.92 | $102.74 | $106.70 | 0.00% |
| Jul 17 | $98.48 | $102.74 | $107.18 | 0.00% |
| Jul 18 | $98.09 | $102.74 | $107.62 | 0.00% |
| Jul 19 | $97.72 | $102.74 | $108.02 | 0.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $97.72 | $102.74 | $108.02 | 0.00% |
| Week 2 | $95.72 | $102.74 | $110.28 | 0.00% |
| Week 3 | $94.21 | $102.74 | $112.05 | 0.00% |
| Week 4 | $92.95 | $102.74 | $113.57 | 0.00% |
| Week 5 | $91.86 | $102.74 | $114.92 | 0.00% |
| Week 6 | $90.88 | $102.75 | $116.15 | +0.01% |
| Week 7 | $90.00 | $102.75 | $117.30 | +0.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LeMaitre Vascular, Inc. is a Healthcare company that develops, manufactures, and markets medical devices and implants used in vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. Its portfolio includes allografts, embolectomy catheters, thrombectomy catheters, occlusion catheters, perfusion catheters, and vascular tissue services, along with biologic patches, vascular grafts, carotid shunts, biosynthetic grafts, phlebectomy systems, LifeSpan vascular grafts, and related closure systems.
The company markets its products through a direct sales force and distributors. It was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001.
LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
LMAT is a healthcare stock focused on vascular surgery devices and implants. It currently trades at $102.88 per share, with a market cap of $2.35B and a market rank of 1882.
A major floor 20.3% below — a decisive break under it would weaken the trend.
The nearest floor, 13.8% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 14.3% above — clearing it would confirm fresh momentum.
Key LMAT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LMAT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $103.28 | Sell | $102.32 | Buy |
| MA 10 | $100.56 | Buy | $100.63 | Buy |
| MA 20 | $96.41 | Buy | $98.61 | Buy |
| MA 50 | $98.64 | Buy | $98.99 | Buy |
| MA 100 | $103.23 | Sell | $99.01 | Buy |
| MA 200 | $94.59 | Buy | $96.43 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.17 | Neutral |
| Stoch RSI (14) | 75.55 | Neutral |
| CCI (20) | 97.84 | Neutral |
| Williams %R (14) | -17.32 | Info |
| MACD (12,26,9) | 1.24 | Buy |
| ROC (12) | 11.73 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 82.68 | Sell |
| TRIX (15) | 0.05 | Buy |
| Awesome (5,34) | 7.52 | Buy |
| Ultimate (7,14,28) | 69.21 | Neutral |
| Momentum (10) | 8.81 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 103.93 | Sell |
| ADX (14) | 21.08 | Buy |
| ATR (14) | 1.67 | Info |
The 30-day technical picture is bullish, supported by a strong near-term setup. RSI14 is 60, signaling room to move without being overbought. The stock’s price is above both the SMA50 ($99.63) and the SMA200 ($94.32), hinting at positive momentum in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $80.17 | $102.74 | $131.66 | 0% | Neutral | |
| $95.28 | $116.38 | $148.63 | +13% | Neutral | |
| $102.14 | $127.11 | $166.74 | +24% | Bullish | |
| $106.15 | $134.14 | $179.73 | +31% | Bullish | |
| $123.31 | $157.95 | $215.45 | +54% | Bullish | |
| $150.88 | $195.63 | $271.09 | +90% | Bullish | |
| $156.18 | $204.80 | $287.84 | +99% | Bullish | |
| $166.43 | $220.55 | $314.00 | +115% | Bullish | |
| $178.87 | $239.40 | $344.94 | +133% | Bullish | |
| $177.58 | $239.94 | $349.57 | +134% | Bullish | |
| $273.85 | $386.01 | $589.44 | +276% | Bullish | |
| $467.63 | $707.22 | $1,157.88 | +588% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $80.17 | $102.74 | $121.82 | +0.00% |
| August 2026 | $86.64 | $101.44 | $121.36 | -1.26% |
| September 2026 | $87.34 | $102.75 | $123.88 | +1.29% |
| October 2026 | $89.96 | $106.27 | $128.97 | +3.42% |
| November 2026 | $90.25 | $106.98 | $130.55 | +0.67% |
| December 2026 | $90.26 | $107.34 | $131.66 | +0.34% |
Click any year to see its month-by-month LMAT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, LMAT is projected to trade between $80.17 and $131.66, averaging $102.74 — a potential gain of 0% from today's $102.74. A consolidation phase looks the most probable path here.
LeMaitre Vascular, Inc.'s 2027 outlook centres on $116.38, within a $95.28 to $148.63 range. That is up +13% on the projected 2026 average. That marks a +13% change versus current levels. Price action looks broadly range-bound.
By 2028, LMAT could reach as high as $166.74, with a base case around $127.11 and support toward $102.14 — roughly +24% from $102.74. Buyers look set to stay in control over this stretch.
Expect LMAT to range from $106.15 to $179.73 through 2029. The $134.14 average target implies a +31% move from current prices. That is up +6% on the projected 2028 average. Momentum favours further upside here.
The LMAT price prediction for 2030 points to an average of $157.95 (low $123.31, high $215.45) — a potential gain of +54% on today's $102.74. Buyers look set to stay in control over this stretch.
In 2031, LMAT is projected to trade between $150.88 and $271.09, averaging $195.63 — a potential gain of +90% from today's $102.74. That is up +24% on the projected 2030 average. Momentum favours further upside here.
LeMaitre Vascular, Inc.'s 2032 outlook centres on $204.80, within a $156.18 to $287.84 range. That is up +5% on the projected 2031 average. That marks a +99% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, LMAT could reach as high as $314.00, with a base case around $220.55 and support toward $166.43 — roughly +115% from $102.74. Momentum favours further upside here.
Expect LMAT to range from $178.87 to $344.94 through 2034. The $239.40 average target implies a +133% move from current prices. That is up +9% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The LMAT price prediction for 2035 points to an average of $239.94 (low $177.58, high $349.57) — a potential gain of +134% on today's $102.74. Momentum favours further upside here.
In 2040, LMAT is projected to trade between $273.85 and $589.44, averaging $386.01 — a potential gain of +276% from today's $102.74. That is up +61% on the projected 2035 average. Buyers look set to stay in control over this stretch.
LeMaitre Vascular, Inc.'s 2050 outlook centres on $707.22, within a $467.63 to $1,157.88 range. That is up +83% on the projected 2040 average. That marks a +588% change versus current levels. Momentum favours further upside here.
Investing $1,000 in LMAT today (≈ 9.733307 LMAT) could be worth
$6,883.6
+$5,883.6 (+588%) by 2050 · US Dollar
Based on the average projected LMAT price of $707.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LMATwould be worth at today's price.
$1,000 invested in LMAT on Jul 10, 2025 (≈ 11.661808 LMAT) would be worth
$1,198.13
+$198.13 (+19.8%) today · 1.20× · US Dollar
Based on a LMAT entry price of $85.75 vs. today's $102.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $102.88 | $998.64 | -0.1% |
| 1 month ago | $92.34 | $1,112.63 | +11.3% |
| 3 months ago | $114.62 | $896.35 | -10.4% |
| 6 months ago | $83.83 | $1,225.58 | +22.6% |
| 1 year ago | $85.75 | $1,198.13 | +19.8% |
| All time (5.0y) ago | $60.03 | $1,711.48 | +71.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LMAT forecast.
Our base-case forecast reaches $210.00 around 2033.
Implied market cap at $210.00: $4.8B
The multi-year forecast paints a bullish trajectory. In 2026 the average price is $102.88 with a neutral sentiment and a min of $80.17 and a max of $133.36. By 2030 the average rises to $161.29 with a 56.8% ROI and bullish sentiment.
The forecast continues higher to 2040 (avg $390.95, max $604.52, ROI 280%) and 2050 (avg $730.08, max $1,213.46, ROI 609.6%), both bullish. These are estimates and not guarantees, reflecting potential upside under favorable conditions but subject to market risks and changes in conditions across the healthcare sector.
Tap a question to reveal the answer.
2030 avg $161.29; min $125.14; max $221.79; ROI 56.8%; sentiment bullish.
Forecast shows bullish sentiment from 2027 onward; 2026 neutral; these are estimates and not guaranteed.
The 2050 max is $1,213.46, implying potential above $1,000; these are forecast estimates, not guarantees.
Current price is $102.88.
Market cap is $2.35B.
LeMaitre Vascular, Inc. Community Discussion
0Share your LeMaitre Vascular, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.